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Editorial
Dear Readers,
Breakthrough pain (BtP) in cancer is since several years a hot topic. On one side it is good that this problem 
is discussed on multiple symposia and conferences and doctors are aware of this problem. On the other side 
we all need to look at this phenomenon with a certain criticism as most of the clinical data available is com-
ing from the industrial trials and the independent data are coming up only slowly. Interest in BtP is mainly 
because of the huge market for multiple “quick” fentanyl preparations used to treat BtP. This billion market 
is booming in the USA, but develops much slower in Europe. Two articles in this issue of Advances in Pallia-
tive Medicine are directly and indirectly involved with BtP. First of them (Janecki) is a typical epidemiological 
questionnaire study trying to establish the magnitude of the problem and awareness of doctors. Doctors 
asked about BtP answer in a very similar way as doctors in the US or UK: BtP is a common problem, but the 
treatment, according to Janecki’s respondents is usually adequate with morphine, NSAIDs or even Paraceta-
mol and Tramadol. Indeed, most of the BtP, worldwide is being treated with these drugs and in only very few 
cases a rapid absorption of fentanyl is of great significance. For those few, it is worse to spend money these 
preparations cost. However, the possibility of using fentanyl preparations should not replace careful diagnosis 
and differentiation of pain, which will lead in most cases to effective treatment. 
Surprisingly, among the pains that were diagnosed in a workup of the BtP most were related not to the 
background pain, but compression of peripheral nerves. Some of these patients were described in a papers 
published in Advances [1–3]. Many of these patients, suffering of nerve compression against bony promi-
nences could be successfully treated with local injections with depo-steroids and local anaesthetics. Multiple 
compression syndromes, in literature known as mono-neuropathies, were identified [4] and wait for further 
exploration. The technique of injection is very simple and is in our hospice a bedside procedure. Complications 
are rare. Sometimes patients experience first more pain after infiltration. Sometimes there is a haematoma 
after injection. Important complication would be inhibition of the adrenals by the injected corticosteroids. 
Currently available preparations of triamcinolone di-acetonide and methylprednisolone remain in place of 
injection for a long time, but it does not mean that they could not have systemic toxicity. Especially in pa-
tients with reduced adrenal activity, these drugs may disturb the balance. Review of this systemic toxicity is 
presented in the article by the undersigned. (Zylicz) Less important is transient increase of blood glucose in 
diabetics, which lasts usually not more than couple of days. 
Taking all together it could be said that there is a lot of interest in BtP around. However, most of the 
interest is directed to a generic phenomenon of BtP which when analysed, can be treated with simple and 
inexpensive drugs and measures. Rapid absorption of fentanyl and quick response may be of a great value 
for few patients. New in whole this discussion is that many patients, due to peripheral sensitisation but also 
cachexia, may suffer of nerve compression syndromes which could be treated in a very effective way. This 
treatment, local infiltration with local anaesthetics and corticosteroids is effective, but is not without toxicity 
in some of the patients. I wonder why we still do not have controlled trials in this area. Clinicians should do 
careful weighing of the pros and cons, as usually. Despite disadvantages morphine remains standard in the 
treatment of BtP [5]. 
Other articles in these issue are also worth reading. One is a very illustrative case of primary hyperthyroidism 
falsely diagnosed as metastasised breast cancer (Teodorczyk). Doctors working in Palliative Care should be all 
time “awake” and challenge the diagnosis made by the clinical colleagues. Once a year or two (may be) we 
may be able to correct diagnosis and when this is not too late, it may be of great significance to the patient. 
I myself once admitted a patient with a cachexia with a diagnosis of a lesion in the lung. Because the patient 
refused further diagnosis and therapy, the patient was admitted to our unit. I compared the available X rays 
and asked question whether this may be something else. It appeared to be a tuberculosis! The patient was 
re-directed to the hospital and eventually survived treatment. Keeping him longer in hospice would probably 
end up in his death.
How do we cope with stress, apparently is dependent on our Attachment styles.(Franczak) Secure attach-
ment styles are significant predictors of an ability to cope under difficult circumstances. On the other hand, 
distorted attachment styles create an unfavorable dynamic for dealing with stressful situations, consisting 
of destructive and ineffective behaviors. So, may be in the future, selecting patients who want to work in 
palliative care we may look at their Attachment Styles? This may be of incredible value.
A tool for Phasiotherapist had been developed and tested by Tylinska-Tekielska. This tool should help the 
Physiotherapis to ask the question what does the patient expect from me? Can I fulfil his/her expectations? 
Are we thinking about the same? Answer to this question may be important in development of the relation-
ship between the patient and his physiotherapist.
And finally a very interesting article by Binnebesel. Death at school. How often this surprises and paralyses 
everybody in school. How often the teachers are not able to say a word to their students and they let them 
fully down. The article discusses problems of grief at school and gives some practical indications how to deal 
with this problem.
I hope you will enjoy reading these articles. If you have any remarks, share them with us.
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